QT dispersion and electrical heart field morphology in patients treated with dosulepin

Physiological Research

Volumn 53, Issue 4, 2004, Pages 379-386

  Kittnar, O ^a   Paclt, I ^a   Mlcek M ^a   Slavicek J ^a   Dohnalova A ^a   Havranek S ^a   Brizman, E ^a   Kitzlerova E ^a   Pisvejcova K ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Body surface potential mapping; Dosulepin; Electrocardigraphy; QT dispersion; Tricyclic antidepressants

Indexed keywords

DOSULEPIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; PROPHYLAXIS; QRS COMPLEX; QT DISPERSION; T WAVE; VECTORCARDIOGRAPHY;

ADULT; DEPRESSIVE DISORDER; DOTHIEPIN; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 4143058029     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BALÍKOVÁ M: Selective system of identification and determination of antidepressants and neuroleptics plasma by solid-phase extraction followed by high performance liquid chromatography with photodiode-array detection in analytical toxicology, J Chromatogr 581: 75-81,1992
2. BARR CS, NAAS A, FREEMAN M, STRUTHERS AD: QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: 327-329, 1994.
3. COWAN JC, YUSOFF K, MOORE M, AMOS PA, GOLD AE, BOURKE JP, TANSUPHASWADIKUL S, CAMPBELL RW: Importance of lead selection in QT interval measurement. Am J Cardiol 61: 83-87, 1988.
4. DAY CP, MCCOMB JM, CAMPBELL RWF: QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63: 342-344, 1990.
5. DAY CP, MCCOMB JM, CAMPBELL RWF: QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J 67: 39-41, 1992.
6. GLANCY JM, WESTON PJ, BHULLAR HK, GARRATT CJ, WOODS KL, DE BONO DP: Reproducibility and automatic measurement of QT dispersion. Eur Heart J 17: 1035-1039, 1996.
7. GLASSMAN AH, ROOSE SP, RIVELLI SK, PREUD'HOMME XA: Cardiovascular effects of antidepressant drugs. Nord J. Psychiatry 30 (Suppl): 41-47, 1993.
8. HAMPLOVÁ-PEICHLOVÁ J., KRŮŠEK J., PACLT I., SLAVÍČEK J., LISÁ V., VYSKOČIL F.: Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture. Physiol Res 51: 317-321, 2002.
9. HIGHAM PD, CAMPBELL RWF: QT dispersion. Br Heart J 71: 508-510, 1994.
10. HII JTY, WYSE GD, GILLIS AM, DUFF HJ, SOLYLO MA, MITCHELL BL: Precordial QT interval dispersion as a marker of torsades de pointes. Circulation 86: 1376-1382, 1992.
11. HOHNLOSER SH, VAN DE LOO A, KALUSCHE D, ARENDTS W, QUART B: Does sotalol-induced alteration of QT-dispersion predict drug effectiveness or proarrhythmic hazards? Circulation 88 (Suppl I): I-397, 1993.
12. HOLLISTER LE: Antidepressant agents. Basic and Clinical Pharmacology. BG KATZUNG (ed.), Lange, Chapter 29, 1989, pp 359-367.
13. KAUTZNER J, GANG YI, CAMM AJ, MALIK M: Short- and long-term reproducibility of QT, QTc and QT dispersion measurement in healthy subjects. Pacing Clin Electrophysiol 17: 928-937, 1994.
14. KITTNAR O, ŠŤOVÍČEK P: Contemporary body surface potential mapping in electrocardiology and its perspectives. Physiol Res 42: 141-143, 1993.
15. KITTNAR O, SLAVÍČEK J, VÁVROVÁ M, BARNA M, DOHNALOVÁ A, MÁLKOVÁ A, ASCHERMANN M, HUMHAL J, HRADEC J, KRÁL J: Repolarization pattern of body surface potential maps (BSPM) in coronary artery disease. Physiol Res 42: 123-130, 1993.
16. KITTNAR O, MLČEK M, SLAVÍČEK J, HAVRÁNEK Š, BRIZMAN E, PACLT I, KITZLEROVÁ E: QT dispersion in psychiatric patients treated with dosulepin in correlation with dosulepin plasma levels. Physiol Res 53: 30P, 2003.
17. KITZLEROVÁ E., SLAVÍČEK J., PACLT I, PIŠVEJCOVÁ K, DOHNALOVÁ A: Plasma levels of dosulepine and heart electric field. Physiol Res 53: 319-325, 2003.
18. LECHMANOVÁ M, KITTNAR O, MLČEK M, SLAVÍČEK J, DOHNALOVÁ A, HAVRÁNEK Š, KOLAŘÍK, M, PAŘÍZEK A: QT dispersion and T-loop morphology in late pregnancy and after delivery. Physiol Res 51: 121-129, 2002.
19. LEONARD BE: Fundamentals of Psychopharmacology, John Wiley, Chichester, 1994, 267 p.
20. LINKER NJ, COLONNA P, KEKWICK CA, TILL J, CAMM AJ, WARD DE: Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69: 634-638, 1992.
21. MIRVIS DM: Spatial variation of the QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol 5: 625-631, 1985.
22. PRESKORN SH, FAST GA: Therapeutic drug monitoring for antidepressants: efficacy, safety and effectiveness. J Clin Psychiatry 52 (Suppl): 23-33, 1991.
23. PRIORI SG, NAPOLITANO C, DIEHL L, SCHWART PJ: Dispersion of the QT interval: a marker of therapeutic efficacy in the long QT syndrome. Circulation 89: 1681-89, 1994.
24. RAWLING D, FOZZARD AH: Effects of imipramine on cellular electrophysiological properties of cardiac Purkinje fibers. J Pharmacol Exp Ther 209: 371-375, 1979.
25. RAY WA, GRIFFIN MR, SCHAFFNER W, BAUGH DK, MELTON LJ: Psychotropic drug use and the risk of hip fracture. N Engl J Med 316: 363-369, 1987.
26. RUTTKAY-NEDECKÝ I: Electric Field of the Heart (in Slovak), Veda, Bratislava, 1983.
27. SINGH N, SINGH KH, KHAN AI: Serial Electrocardiographic Changes as a predictor of cardiovascular toxicity in acute tricyclic antidepressant overdose. Am J Ther 9: 75-79, 2002.
28. SLAVÍČEK J, KITZLEROVÁ E, PACLT I, KITTNAR O: Dose- and plasma level-dependent dosulepine changes in heart electric field in depressive women. Physiol Res 53: 39P, 2003.
29. SOMBERG J, TEPPER D, WYNN J: Prolonged repolarisation: a historical perspective. Am Heart J 109: 395-398, 1985.
30. SPORTON SC, TAGGART P, SUTTON PM, WALKER JM, HARDMAN SM: Acute ischaemia: a dynamic influence on QT dispersion. Lancet 349: 306-309, 1997.
31. STOUDEMIRE A., FOGEL BS: Psychopharmacology in the medically ill. In: Principles of Medical Psychiatry, STOUDEMIRE A, FOGEL BS (eds), Grune & Stratton, Orlando, 1987, pp 79-112.
32. ŠVESTKA J.: Third-, fourth- and fifth- generation antidepressants (in Czech). Čs psychiatr 90: 3-19, 1994.
33. ŠVORC P, WILK P, MURÁR J, PODLUBNÝ I, KUJANÍK S, BRAČOKOVÁ I, MURÍN M: Circadian rhythm of the ventricular fibrillation threshold in female Wistar rats. Physiol Res 43: 355-358, 1994.
34. ŠVORC P, BRAČOKOVÁ I, PODLUBNÝ I: Relation of ventricular fibrillation threshold to heart rate during normal ventilation and hypoventilation in female Wistar rats: a chronophysiological study. Physiol Res 49: 711-9, 2000.
35. VAN DE LOO A, ARENDTS W, HOHNLOSER SH: Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 74: 1113-1118, 1994.
36. WARRINGTON SJ, PACHAM C, LADER M: The cardiovascular effect of antidepressants. Psychol Med 16 (Suppl): 1-40, 1989.
37. WELD FM, BIGGERT JT: Electrophysiological effects of imipramine on ovine cardiac Purkinje and ventricular muscle fibres. Circ Res 46: 167-175, 1980.